Naegis Pharmaceuticals Inc.
New Filing
CIK: 0002021578·Other·BRITISH COLUMBIA, CANADA·Filed: May 2, 2024
Total Offering
$350,812
Amount Sold
$350,812
Investors
4
First Sale
Apr 19, 2024
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Ian McBeath | Related Person |
| David Burgoyne | Related Person |
| Philip Davies | Related Person |
| Michael Liggett | Related Person |
| Cameron Groome | Related Person |
| Julian Gangolli | Related Person |
Company
SEC Filing
0002021578-24-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free